Annual EBIT
$4.67 M
+$16.80 M+138.50%
November 30, 2024
Summary
- As of March 10, 2025, CCEL annual earnings before interest & taxes is $4.67 million, with the most recent change of +$16.80 million (+138.50%) on November 30, 2024.
- During the last 3 years, CCEL annual EBIT has risen by +$678.60 thousand (+17.01%).
- CCEL annual EBIT is now -29.08% below its all-time high of $6.58 million, reached on November 30, 2020.
Performance
CCEL EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$96.90 K
-$2.01 M-105.06%
November 30, 2024
Summary
- As of March 10, 2025, CCEL quarterly earnings before interest & taxes is -$96.90 thousand, with the most recent change of -$2.01 million (-105.06%) on November 30, 2024.
- Over the past year, CCEL quarterly EBIT has dropped by -$2.01 million (-105.06%).
- CCEL quarterly EBIT is now -104.20% below its all-time high of $2.31 million, reached on November 30, 2020.
Performance
CCEL Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$4.67 M
+$16.07 M+140.97%
November 30, 2024
Summary
- As of March 10, 2025, CCEL TTM earnings before interest & taxes is $4.67 million, with the most recent change of +$16.07 million (+140.97%) on November 30, 2024.
- Over the past year, CCEL TTM EBIT has increased by +$16.07 million (+140.97%).
- CCEL TTM EBIT is now -34.40% below its all-time high of $7.12 million, reached on August 31, 2021.
Performance
CCEL TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CCEL EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +138.5% | -105.1% | +141.0% |
| 3 y3 years | +17.0% | -106.3% | -10.7% |
| 5 y5 years | -8.4% | -106.3% | -10.7% |
CCEL EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3.5% | +138.5% | -105.1% | +99.4% | -10.7% | +136.6% |
| 5 y | 5-year | -29.1% | +138.5% | -104.2% | +99.4% | -34.4% | +136.6% |
| alltime | all time | -29.1% | +138.5% | -104.2% | +99.4% | -34.4% | +136.6% |
Cryo-Cell International EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | $4.67 M(-138.5%) | -$96.90 K(-105.1%) | $4.67 M(-141.0%) |
| Aug 2024 | - | $1.91 M(+6.2%) | -$11.40 M(-3.2%) |
| May 2024 | - | $1.80 M(+71.4%) | -$11.77 M(-7.7%) |
| Feb 2024 | - | $1.05 M(-106.5%) | -$12.76 M(+5.2%) |
| Nov 2023 | -$12.13 M(-350.5%) | -$16.16 M(-1151.3%) | -$12.13 M(-331.8%) |
| Aug 2023 | - | $1.54 M(+88.3%) | $5.23 M(+11.3%) |
| May 2023 | - | $816.40 K(-51.4%) | $4.70 M(-7.1%) |
| Feb 2023 | - | $1.68 M(+40.5%) | $5.06 M(+4.5%) |
| Nov 2022 | $4.84 M(+21.3%) | $1.20 M(+18.9%) | $4.84 M(+71.5%) |
| Aug 2022 | - | $1.01 M(-14.5%) | $2.82 M(-17.3%) |
| May 2022 | - | $1.18 M(-19.5%) | $3.41 M(-19.1%) |
| Feb 2022 | - | $1.46 M(-277.8%) | $4.22 M(+5.7%) |
| Nov 2021 | $3.99 M(-39.4%) | -$822.20 K(-151.5%) | $3.99 M(-43.9%) |
| Aug 2021 | - | $1.60 M(-19.4%) | $7.12 M(+4.7%) |
| May 2021 | - | $1.98 M(+60.8%) | $6.80 M(+4.4%) |
| Feb 2021 | - | $1.23 M(-46.5%) | $6.51 M(-1.1%) |
| Nov 2020 | $6.58 M(+29.2%) | $2.31 M(+80.9%) | $6.58 M(+9.2%) |
| Aug 2020 | - | $1.27 M(-25.0%) | $6.03 M(-11.1%) |
| May 2020 | - | $1.70 M(+30.2%) | $6.78 M(+20.8%) |
| Feb 2020 | - | $1.30 M(-25.4%) | $5.61 M(+10.1%) |
| Nov 2019 | $5.09 M(-1.3%) | $1.75 M(-13.8%) | $5.09 M(-6.3%) |
| Aug 2019 | - | $2.03 M(+283.6%) | $5.44 M(+24.5%) |
| May 2019 | - | $528.90 K(-32.8%) | $4.37 M(-12.6%) |
| Feb 2019 | - | $787.50 K(-62.4%) | $5.00 M(-3.2%) |
| Nov 2018 | $5.16 M(+4.8%) | $2.09 M(+118.4%) | $5.16 M(+20.2%) |
| Aug 2018 | - | $958.40 K(-17.3%) | $4.30 M(-10.4%) |
| May 2018 | - | $1.16 M(+21.6%) | $4.80 M(+0.1%) |
| Feb 2018 | - | $953.60 K(-22.2%) | $4.79 M(-2.8%) |
| Nov 2017 | $4.93 M(-421.4%) | $1.23 M(-15.9%) | $4.93 M(+17.5%) |
| Aug 2017 | - | $1.46 M(+26.3%) | $4.19 M(-787.2%) |
| May 2017 | - | $1.15 M(+5.9%) | -$609.90 K(+4.9%) |
| Feb 2017 | - | $1.09 M(+122.3%) | -$581.60 K(-62.1%) |
| Nov 2016 | -$1.53 M(-168.0%) | $490.20 K(-114.7%) | -$1.53 M(-31.6%) |
| Aug 2016 | - | -$3.34 M(-382.8%) | -$2.24 M(-195.1%) |
| May 2016 | - | $1.18 M(+754.3%) | $2.36 M(+32.4%) |
| Feb 2016 | - | $138.40 K(-164.0%) | $1.78 M(-21.1%) |
| Nov 2015 | $2.25 M(+23.2%) | -$216.40 K(-117.3%) | $2.25 M(-10.4%) |
| Aug 2015 | - | $1.25 M(+106.8%) | $2.51 M(+37.1%) |
| May 2015 | - | $605.20 K(-1.3%) | $1.83 M(+6.5%) |
| Feb 2015 | - | $612.90 K(+1265.0%) | $1.72 M(-5.8%) |
| Nov 2014 | $1.83 M(+14.5%) | $44.90 K(-92.1%) | $1.83 M(-18.1%) |
| Aug 2014 | - | $571.30 K(+15.7%) | $2.23 M(+0.9%) |
| May 2014 | - | $493.70 K(-31.3%) | $2.21 M(+24.3%) |
| Feb 2014 | - | $718.70 K(+60.5%) | $1.78 M(+11.4%) |
| Nov 2013 | $1.60 M(-147.0%) | $447.70 K(-18.9%) | $1.60 M(+176.3%) |
| Aug 2013 | - | $551.70 K(+800.0%) | $578.20 K(-314.1%) |
| May 2013 | - | $61.30 K(-88.6%) | -$270.00 K(-82.4%) |
| Feb 2013 | - | $536.90 K(-193.9%) | -$1.54 M(-54.8%) |
| Nov 2012 | -$3.40 M(+627.7%) | -$571.70 K(+92.8%) | -$3.40 M(+29.1%) |
| Aug 2012 | - | -$296.50 K(-75.4%) | -$2.63 M(-38.4%) |
| May 2012 | - | -$1.20 M(-9.2%) | -$4.27 M(+73.7%) |
| Feb 2012 | - | -$1.33 M(-779.9%) | -$2.46 M(+460.0%) |
| Nov 2011 | -$466.90 K(-113.8%) | $195.00 K(-110.1%) | -$438.70 K(-335.2%) |
| Aug 2011 | - | -$1.93 M(-418.1%) | $186.50 K(-94.0%) |
| May 2011 | - | $607.90 K(-12.2%) | $3.12 M(-6.1%) |
| Feb 2011 | - | $692.40 K(-15.6%) | $3.33 M(-1.3%) |
| Nov 2010 | $3.37 M | $820.20 K(-18.1%) | $3.37 M(+31.3%) |
| Aug 2010 | - | $1.00 M(+23.4%) | $2.57 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2010 | - | $811.80 K(+10.0%) | $2.42 M(-14.5%) |
| Feb 2010 | - | $737.90 K(+4427.0%) | $2.83 M(-5.8%) |
| Nov 2009 | $2.96 M(+322.8%) | $16.30 K(-98.1%) | $3.00 M(-27.9%) |
| Aug 2009 | - | $852.60 K(-30.3%) | $4.17 M(+29.0%) |
| May 2009 | - | $1.22 M(+34.2%) | $3.23 M(+88.0%) |
| Feb 2009 | - | $911.80 K(-22.7%) | $1.72 M(+166.1%) |
| Nov 2008 | $700.70 K(-115.0%) | $1.18 M(-1495.6%) | $645.70 K(-134.5%) |
| Aug 2008 | - | -$84.50 K(-70.7%) | -$1.87 M(-33.1%) |
| May 2008 | - | -$288.40 K(+79.5%) | -$2.80 M(-29.4%) |
| Feb 2008 | - | -$160.70 K(-88.0%) | -$3.97 M(-15.1%) |
| Nov 2007 | -$4.67 M(+57.9%) | -$1.34 M(+32.5%) | -$4.67 M(+7.2%) |
| Aug 2007 | - | -$1.01 M(-30.4%) | -$4.36 M(-0.7%) |
| May 2007 | - | -$1.45 M(+67.8%) | -$4.39 M(+18.2%) |
| Feb 2007 | - | -$866.30 K(-15.6%) | -$3.71 M(+25.5%) |
| Nov 2006 | -$2.96 M(-341.8%) | -$1.03 M(-1.6%) | -$2.96 M(+114.2%) |
| Aug 2006 | - | -$1.04 M(+33.8%) | -$1.38 M(-513.2%) |
| May 2006 | - | -$779.40 K(+597.8%) | $334.40 K(-60.4%) |
| Feb 2006 | - | -$111.70 K(-120.2%) | $845.30 K(-30.9%) |
| Nov 2005 | $1.22 M(-61.5%) | $552.00 K(-18.0%) | $1.22 M(+50.8%) |
| Aug 2005 | - | $673.50 K(-350.8%) | $811.60 K(-62.5%) |
| May 2005 | - | -$268.50 K(-200.6%) | $2.17 M(-31.8%) |
| Feb 2005 | - | $267.00 K(+91.3%) | $3.18 M(-0.2%) |
| Nov 2004 | $3.18 M(-146.9%) | $139.60 K(-93.1%) | $3.18 M(-304.9%) |
| Aug 2004 | - | $2.03 M(+173.0%) | -$1.55 M(-63.2%) |
| May 2004 | - | $742.80 K(+172.7%) | -$4.22 M(-27.2%) |
| Feb 2004 | - | $272.40 K(-105.9%) | -$5.80 M(-17.1%) |
| Nov 2003 | -$6.78 M(+13.7%) | -$4.60 M(+619.2%) | -$6.99 M(+3.7%) |
| Aug 2003 | - | -$639.00 K(-23.3%) | -$6.74 M(-2.9%) |
| May 2003 | - | -$833.40 K(-9.4%) | -$6.94 M(+2.8%) |
| Feb 2003 | - | -$919.60 K(-78.8%) | -$6.75 M(+13.2%) |
| Nov 2002 | -$5.96 M(+1127.2%) | -$4.34 M(+415.0%) | -$5.96 M(+186.8%) |
| Aug 2002 | - | -$843.50 K(+31.2%) | -$2.08 M(+57.9%) |
| May 2002 | - | -$642.70 K(+384.0%) | -$1.32 M(+496.7%) |
| Feb 2002 | - | -$132.80 K(-71.2%) | -$220.70 K(-54.6%) |
| Nov 2001 | -$485.90 K(-77.5%) | -$460.50 K(+469.2%) | -$485.80 K(-30.9%) |
| Aug 2001 | - | -$80.90 K(-117.8%) | -$703.20 K(-40.8%) |
| May 2001 | - | $453.50 K(-214.0%) | -$1.19 M(-45.8%) |
| Feb 2001 | - | -$397.90 K(-41.3%) | -$2.19 M(+1.4%) |
| Nov 2000 | -$2.16 M(+116.1%) | -$677.90 K(+19.9%) | -$2.16 M(+190.0%) |
| Aug 2000 | - | -$565.20 K(+2.5%) | -$745.20 K(-24.0%) |
| May 2000 | - | -$551.20 K(+50.3%) | -$980.00 K(+18.2%) |
| Feb 2000 | - | -$366.80 K(-149.7%) | -$828.80 K(-3.9%) |
| Nov 1999 | -$1.00 M(-54.5%) | $738.00 K(-192.3%) | -$862.00 K(-60.8%) |
| Aug 1999 | - | -$800.00 K(+100.0%) | -$2.20 M(+15.8%) |
| May 1999 | - | -$400.00 K(0.0%) | -$1.90 M(-5.0%) |
| Feb 1999 | - | -$400.00 K(-33.3%) | -$2.00 M(+5.3%) |
| Nov 1998 | -$2.20 M(+46.7%) | -$600.00 K(+20.0%) | -$1.90 M(0.0%) |
| Aug 1998 | - | -$500.00 K(0.0%) | -$1.90 M(+11.8%) |
| May 1998 | - | -$500.00 K(+66.7%) | -$1.70 M(+13.3%) |
| Feb 1998 | - | -$300.00 K(-50.0%) | -$1.50 M(+25.0%) |
| Nov 1997 | -$1.50 M(-287.5%) | -$600.00 K(+100.0%) | -$1.20 M(-36.8%) |
| Aug 1997 | - | -$300.00 K(0.0%) | -$1.90 M(+111.1%) |
| May 1997 | - | -$300.00 K(<-9900.0%) | -$900.00 K(-1000.0%) |
| Feb 1997 | - | $0.00(-100.0%) | $100.00 K(-87.5%) |
| Nov 1996 | $800.00 K | -$1.30 M(-285.7%) | $800.00 K(-61.9%) |
| Aug 1996 | - | $700.00 K(0.0%) | $2.10 M(+50.0%) |
| May 1996 | - | $700.00 K(0.0%) | $1.40 M(+100.0%) |
| Feb 1996 | - | $700.00 K | $700.00 K |
FAQ
- What is Cryo-Cell International annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cryo-Cell International?
- What is Cryo-Cell International annual EBIT year-on-year change?
- What is Cryo-Cell International quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cryo-Cell International?
- What is Cryo-Cell International quarterly EBIT year-on-year change?
- What is Cryo-Cell International TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cryo-Cell International?
- What is Cryo-Cell International TTM EBIT year-on-year change?
What is Cryo-Cell International annual earnings before interest & taxes?
The current annual EBIT of CCEL is $4.67 M
What is the all time high annual EBIT for Cryo-Cell International?
Cryo-Cell International all-time high annual earnings before interest & taxes is $6.58 M
What is Cryo-Cell International annual EBIT year-on-year change?
Over the past year, CCEL annual earnings before interest & taxes has changed by +$16.80 M (+138.50%)
What is Cryo-Cell International quarterly earnings before interest & taxes?
The current quarterly EBIT of CCEL is -$96.90 K
What is the all time high quarterly EBIT for Cryo-Cell International?
Cryo-Cell International all-time high quarterly earnings before interest & taxes is $2.31 M
What is Cryo-Cell International quarterly EBIT year-on-year change?
Over the past year, CCEL quarterly earnings before interest & taxes has changed by -$2.01 M (-105.06%)
What is Cryo-Cell International TTM earnings before interest & taxes?
The current TTM EBIT of CCEL is $4.67 M
What is the all time high TTM EBIT for Cryo-Cell International?
Cryo-Cell International all-time high TTM earnings before interest & taxes is $7.12 M
What is Cryo-Cell International TTM EBIT year-on-year change?
Over the past year, CCEL TTM earnings before interest & taxes has changed by +$16.07 M (+140.97%)